1
项与 对乙酰氨基酚/卡立普多/咖啡因 相关的临床试验National, Phase III, Monocentric, Randomized, Double-blind, Controlled, Parallel, to Evaluate the Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain.
National clinical trial, phase III, monocentric, randomized, double-blind, controlled, parallel, study of superiority, in which two hundred and thirty four (234) participants of both sexes, aged equal or more than 18 years and equal or less than 54 years, will be randomly allocated in one of two treatment groups. The first group will use Dorilax® plus thermal band and the second group will use thermal band plus placebo. The results will show the efficacy and security of Dorilax® and compare the efficiency of Dorilax® and thermal band.
100 项与 对乙酰氨基酚/卡立普多/咖啡因 相关的临床结果
100 项与 对乙酰氨基酚/卡立普多/咖啡因 相关的转化医学
100 项与 对乙酰氨基酚/卡立普多/咖啡因 相关的专利(医药)
100 项与 对乙酰氨基酚/卡立普多/咖啡因 相关的药物交易